Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer

Siegel R.L. Miller K.D. Fuchs H.E. Jemal A.

Cancer statistics, 2022.

CA Cancer J Clin. 72: 7-33

Cancer stat facts: uterine cancer. National Cancer Institute Surveillance, Epidemiology, and End Results Program. https://seer.cancer.gov/statfacts/html/corp.html (accessed 4/7/2022).

Uterine neoplasms. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). National Comprehensive Cancer Network. http://www.nccn.org (accesssed 4/7/2022).

Morice P. Leary A. Creutzberg C. Abu-Rustum N. Darai E.

Endometrial cancer.

Lancet. 387: 1094-1108Wright J.D. Barrena Medel N.I. Sehouli J. Fujiwara K. Herzog T.J.

Contemporary management of endometrial cancer.

Lancet. 379: 1352-1360

The AJCC Cancer Staging Manual, 8th edition, 2017, Springer.

Bogani G. Mariani A. Paolini B. Ditto A. Raspagliesi F.

Low-volume disease in endometrial cancer: The role of micrometastasis and isolated tumor cells.

Gynecol Oncol. 153: 670-675

Matsuo K, Klar M, Nusbaum DJ, Hasanov MF, Vallejo A, Ciesielski KM, Muderspach LI, Roman LD, Wright JD. Utilization and outcomes of sentinel lymph node biopsy for early endometrial cancer. Obstet Gynecol 2022;in-press. https://journals.lww.com/greenjournal/Abstract/9900/Utilization_and_Outcomes_of_Sentinel_Lymph_Node.426.aspx#.

Wright J.D. Cham S. Chen L. Burke W.M. Hou J.Y. Tergas A.I. et al.

Utilization of sentinel lymph node biopsy for uterine cancer.

Am J Obstet Gynecol. 216: 594.e1-594.e13

Dioun S, Chen L, Melamed A, et al. Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancer. BJOG. 2021;in-press.

García Pineda V. Hernández Gutiérrez A. Gracia Segovia M. Siegrist Ridruejo J. Diestro Tejeda M.D. Zapardiel I.

Low-Volume Nodal Metastasis in Endometrial Cancer: Risk Factors and Prognostic Significance.

J Clin Med. 9: 1999Ghoniem K. Larish A.M. Dinoi G. Zhou X.C. Alhilli M. Wallace S. et al.

Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional study.

Gynecol Oncol. 162: 590-598Gómez-Hidalgo N.R. Ramirez P.T. Ngo B. Pérez-Hoyos S. Coreas N. Sanchez-Iglesias J.L. et al.

Oncologic impact of micrometastases or isolated tumor cells in sentinel lymph nodes of patients with endometrial cancer: a meta-analysis.

Clin Transl Oncol. 22: 1272-1279Kim C.H. Soslow R.A. Park K.J. Barber E.L. Khoury-Collado F. Barlin J.N. et al.

Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging.

Int J Gynecol Cancer. 23: 964-970St. Clair C.M. Eriksson A.G.Z. Ducie J.A. Jewell E.L. Alektiar K.M. Hensley M.L. et al.

Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma.

Ann Surg Oncol. 23: 1653-1659Kim C.H. Khoury-Collado F. Barber E.L. Soslow R.A. Makker V. Leitao M.M. et al.

Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.

Gynecol Oncol. 131: 714-719Frimer M. Khoury-Collado F. Murray M.P. Barakat R.R. Abu-Rustum N.R.

Micrometastasis of endometrial cancer to sentinel lymph nodes: is it an artifact of uterine manipulation?.

Gynecol Oncol. 119: 496-499Ferraioli D. Chopin N. Beurrier F. Carrabin N. Buenerd A. Mathevet P.

The incidence and clinical significance of the micrometastases in the sentinel lymph nodes during surgical staging for early endometrial cancer.

Int J Gynecol Cancer. 25: 673-680Touhami O. Gregoire J. Renaud M.C. Sebastianelli A. Plante M.

Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.

Gynecol Oncol. 147: 549-553Rossi E.C. Kowalski L.D. Scalici J. Cantrell L. Schuler K. Hanna R.K. et al.

A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.

Lancet Oncol. 18: 384-392Eriksson A.G.Z. Ducie J. Ali N. McGree M.E. Weaver A.L. Bogani G. et al.

Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.

Gynecol Oncol. 140: 394-399Clinton L.K. Kondo J. Carney M.E. Tauchi-Nishi P. Terada K. Shimizu D.

Low-volume lymph node metastases in endometrial carcinoma.

Int J Gynecol Cancer. 27: 1165-1170Plante M. Stanleigh J. Renaud M.C. Sebastianelli A. Grondin K. Gregoire J.

Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?.

Gynecol Oncol. 146: 240-246

National Cancer Institute's The Surveillance, Epidemiology, and End Results (SEER) Program. <http://seer.cancer.gov/> (accessed 4/7/2022).

Zippin C. Lum D. Hankey B.F.

Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute.

Cancer. 76: 2343-2350

National Cancer Registrars Association <http://www.ncra-usa.org/> (accessed 4/7/2022).

Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.

Stat Med. 34: 3661-3679

Cohen J. Statistical Power Analysis for the Behavioral Sciences.2nd ed.1988.ErlbaumHillsdale, NJ.

Ghaferi A.A. Schwartz T.A. Pawlik T.M.

STROBE reporting guidelines for observational studies.

JAMA Surg. 156: 577-578Ballester M. Dubernard G. Lécuru F. Heitz D. Mathevet P. Marret H. et al.

Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).

Lancet Oncol. 12: 469-476Cusimano M.C. Vicus D. Pulman K. Maganti M. Bernardini M.Q. Bouchard-Fortier G. et al.

Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging.

JAMA Surg. 156: 157Frumovitz M. Plante M. Lee P.S. Sandadi S. Lilja J.F. Escobar P.F. et al.

Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial.

Lancet Oncol. 19: 1394-1403Soliman P.T. Westin S.N. Dioun S. Sun C.C. Euscher E. Munsell M.F. et al.

A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.

Gynecol Oncol. 146: 234-239

Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging.

J Natl Compr Canc Netw. 12: 288-297Koh W.J. Greer B.E. Abu-Rustum N.R. et al.

Uterine neoplasms, version 1.2014.

J Natl Compr Canc Netw. 12: 248-280Matsuo K. Klar M. Khetan V.U. Violette C.J. Nusbaum D.J. Muderspach L.I. et al.

Sentinel lymph node biopsy for stage II endometrial cancer: recent utilization and outcome in the United States.

Gynecol Oncol. 164: 46-52Kosťun J. Pešta M. Sláma J. Slunéčko R. Vlasák P. Bouda J. et al.

Presl J One-step nucleic acid amplification vs ultrastaging in the detection of sentinel lymph node metastasis in endometrial cancer patients.

J Surg Oncol. 119: 361-369Creasman W.T. Ali S. Mutch D.G. Zaino R.J. Powell M.A. Mannel R.S. et al.

Surgical-pathological findings in type 1 and 2 endometrial cancer: an NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol.

Gynecol Oncol. 145: 519-525

留言 (0)

沒有登入
gif